Featured Jobs
|
EPIC RPS
|
|
Internal Channel Sales Team Lead July Business Services
|
|
Experienced Employee Benefits Attorney Shipman & Goodwin LLP
|
|
Relationship Manager – Defined Contributions Daybright Financial
|
|
Nova 401(k) Associates
|
|
Regional Sales Director-Heartland July Business Services
|
|
Spectrum Pension Consultants (part of Daybright Financial)
|
|
Independent Retirement
|
|
EPIC RPS
|
|
Daybright Financial
|
|
Director of Regulatory Operations and Compliance PCS Retirement
|
|
Daybright Financial
|
|
Stones River Consulting
|
|
Regional Sales Director-Mid Atlantic July Business Services
|
|
Director, Strategic Accounts and Channel Development July Business Services
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
Search the News Archive
|
2 Matching News Items |
| 1. |
Uwe E. Reinhardt, The New York Times via Physicians for a National Health Program [PNHP]
May 26, 2009
Excerpt: With another 'national conversation' about health reform upon us -- as it is every decade or so -- we will hear a lot of derisive talk about the evils of 'socialized medicine.' The term is regularly confused with 'social health insurance,' which is not at all the same concept. The chart [followed by text explanations in the article] may be helpful in appreciating the distinction.
|
| 2. |
The New York Times and Uwe E. Reinhardt via Physicians for a National Health Program [PNHP]
Dec. 9, 2008
Excerpt: [R]esearch around the world has shown that the process of the aging of the population by itself adds only a very small part -- usually about half a percentage point -- to the annual growth in per-capita health spending in industrialized societies, which tends to range between 5 and 8 percent, depending on the country and the period in question. The bulk of annual spending growth can be explained by overall population growth (about 1.1 percent per year), increases in the prices of health care goods and services, and the availability of ever more new, often high-cost medical products and treatments used by all age groups.
|
|
Syntax Enhancements for Standard Searches
|